Nutex Health (US:NUTX) Prnewswireยท2025-03-31 20:30Core Insights - Nutex Health Inc. reported significant financial growth for the fiscal year 2024, with total revenue reaching $479.9 million, a 93.8% increase from $247.6 million in 2023 [5] - The company achieved a net income of $52.2 million compared to a net loss of $45.8 million in the previous year, marking a substantial turnaround [5] - The arbitration process initiated in July 2024 contributed approximately $169.7 million in additional revenue, accounting for 73.1% of the overall revenue increase [5][8] Financial Performance - Total revenue for the year ended December 31, 2024, was $479.9 million, up from $247.6 million in 2023, reflecting a growth of $232.3 million [5] - Net income for the year was $52.2 million, a significant improvement from the net loss of $45.8 million in 2023 [5] - EBITDA for the year was $98.4 million, compared to a negative EBITDA of $(22.5) million in 2023 [5] - Adjusted EBITDA reached $123.7 million, a remarkable increase of 1,045.4% from $10.8 million in 2023 [5] Quarterly Highlights - For the fourth quarter of 2024, total revenue was $257.6 million, a 269.6% increase from $69.7 million in the same quarter of 2023 [5] - Net income for the fourth quarter was $61.7 million, compared to a net loss of $31.7 million in the fourth quarter of 2023 [5] - Total visits at the Hospital Division increased by 16.9% year-over-year, with mature hospitals seeing a 6.5% increase in visits [5][7] Operational Metrics - The company operated 24 micro hospitals and outpatient departments across 11 states, focusing on integrated healthcare delivery [2][24] - The arbitration initiative has led to higher reimbursement amounts per visit, aligning more closely with fair market rates [8] - The company plans to continue optimizing operations and maintaining a lean cost structure to support sustained growth in 2025 [7]